EMILY BURKE: Open Payments
NPI 1902311053 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,107 in 50 payments from 19 companies in 2025. Trend: 2023 $1,160 · 2024 $825 · 2025 $1,107
Food & beverage: $1,107
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $181 |
| Otsuka America Pharmaceutical, Inc. | 7 | $157 |
| Fresenius USA Marketing, Inc. | 5 | $112 |
| Mallinckrodt Hospital Products Inc. | 6 | $111 |
| NxStage Medical, Inc. | 1 | $76 |
| Ardelyx, Inc. | 3 | $64 |
| Novartis Pharmaceuticals Corporation | 2 | $58 |
| Novo Nordisk Inc | 1 | $49 |
| Calliditas Therapeutics US Inc. | 2 | $40 |
| AKEBIA THERAPEUTICS INC | 1 | $38 |
Products named: Kerendia, JYNARQUE, VELPHORO, ACTHAR, NXSTAGE SYSTEM ONE, IBSRELA, JARDIANCE, Ozempic.
Industry payments across LA — which companies pay providers there.
